Anthem Biosciences
CEO: Dr Ajay Bhardwaj
Revenue: Rs 350 crore

Bangalore-based CRO Anthem Biosciences registered a total revenue of Rs 350 crore in the fiscal year 2015-16 against Rs 280 crore in FY 14-15.
Anthem Biosciences, is contract research and innovation service provider (CRISP), located in an industrial park in Bangalore with a built-up capacity to house over 500 researchers. Currently, the company employs over 350 people.

Anthem Biosciences' key achievements for the last fiscal include, adding new manufacturing facilities like high potent compounds manufacturing plant, larger microbial and cell culture facility. The company also started construction on a new large scale manufacturing facility.

As a CRISP - Anthem offers a whole gamut of services dedicated to enabling and sustaining global research efforts in the discovery of new compounds by pharmaceutical, biotechnology, specialty chemicals, agriculture chemicals and material science companies.

In discovery research, Anthem provides pharmaceutical clients services from generation of hits, transforming hits to leads and optimization of leads to developable drug candidates against known or client's targets.

In one of the major deals past fiscal, the firm has garnered GMP projects for major pharma and global biotech companies. Another highlight includes global launch of nutrition products developed at Anthem. In addition, the company's new GMP biology labs will open this year.

In the future, Anthem will inaugurate a new large scale manufacturing facility including state of the art fermentation by Q4, GLP accreditation.

Since its inception, the CRO has diversified export base to countries like South America, South-East Asia, the Middle East countries.
In the ever crowding space of CROs, Anthem Biosciences distinguishes itself as a top tier organization, with a highly skilled team, quality services and a guarantee of on-time performance.